Zhiyi Biotech
Latest round
- Series C
Last raised
- Apr 2026
Total raised
- $68M
Investors
- 12
About Zhiyi Biotech
, trading as Zhiyi Biotech, operates as a provider of a biopharmaceutical company that focuses on the research and development of next-generation probiotics and live biotherapeutics. The company has been approved more than 10 projects, including National 863 Special Project and Guangdong Provincial Major New Drug Creation Special Project. It has built a 10,000-square-meter R&D center and pilot plant, including two GMP standard pilot plants. Its SK08(Bacteroides fragilis) was approved for clinical trials in November 2019, Phase II clinical study for safety and tolerability of SK08 has enrolled in 2021. The company has established a technical system for the spectra of microorganisms and pathogenic bacteria, the isolation and target identification of new functional strains as well as the development of new live biotherapeutics and active ingredients. The main product, SK08, is an original biopharmaceutical and an in vivo biopharmaceutical developed using a new strain of Bacteroides Fragilis. The SK10 developed by the company can be used for treatment of chemotherapy-associated diarrhea. The company's revenue is generated by providing R&D services in clinical stage of live biotherapeutics (LBPs) and next-generation probiotics (NGPs).
Who invested in Zhiyi Biotech
12 investors across 6 rounds
See all investors in Zhiyi Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zhiyi Biotech
Who invested in Zhiyi Biotech?
Zhiyi Biotech has 12 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zhiyi Biotech raised?
Zhiyi Biotech has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Zhiyi Biotech last raise money?
Zhiyi Biotech's most recent round on record is a Series C, in Apr 2026.
What does Zhiyi Biotech do?
, trading as Zhiyi Biotech, operates as a provider of a biopharmaceutical company that focuses on the research and development of next-generation probiotics and live biotherapeutics.
Where is Zhiyi Biotech headquartered?
Zhiyi Biotech is headquartered in Guangzhou, China.
Which VCs invest in companies like Zhiyi Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Zhiyi Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Zhiyi Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.